AVANIR PHARMACEUTICALS, INC CL A
AVNR
AVNR was delisted on the 12th of January, 2015.
100 hedge funds and large institutions have $384M invested in AVANIR PHARMACEUTICALS, INC CL A in 2014 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 18 closing their positions.
207% more call options, than puts
Call options by funds: $31.2M | Put options by funds: $10.2M
19% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 32
10% more capital invested
Capital invested by funds: $350M → $384M (+$34.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 101 → 100 (-1)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.21M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.75M |
| 4 |
Goldman Sachs
New York
|
+$1.79M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$6.57M |
| 2 |
AG
Artal Group
Luxembourg
|
-$4.19M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.68M |
| 4 |
Morgan Stanley
New York
|
-$2.68M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.85M |
AVNR Hedge Fund Activity: Q1 2014 in Review
100 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q1 2014, worth a combined $384M — up 9.8% from $350M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of AVNR and 17 opened new positions — a net loss of 1 holder — while 32 trimmed existing stakes and 38 added.
The largest buyer was Fidelity Investments, adding an estimated $12.8M. The largest seller was State Street, cutting an estimated $6.57M.
- 100 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q1 2014, down from 101 in Q4 2013.
- Funds reported $384M of AVANIR PHARMACEUTICALS, INC CL A stock for Q1 2014, up 9.8% quarter-over-quarter.
- 17 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q1 2014 and 18 closed out, a net change of -1 holder.
- The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q1 2014 was Fidelity Investments, an estimated $12.8M added.
- The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q1 2014 was State Street, an estimated $6.57M sold.
Based on aggregated 13F filings for Q1 2014.